PEN-2 gene mutation in a familial Alzheimer's disease case

J Neurol. 2005 Sep;252(9):1033-6. doi: 10.1007/s00415-005-0799-7. Epub 2005 Mar 16.

Abstract

Genetic evidence indicates a central role of cerebral accumulation of beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (AD). Beside presenilin 1 and 2, three other recently discovered proteins (Aph 1, PEN 2 and nicastrin) are associated with gamma-secretase activity, the enzymatic complex generating Abeta. Alterations in genes encoding these proteins were candidates for a role in AD. The PEN 2 gene was examined for unknown mutations and polymorphisms in sporadic and familial Alzheimer patients. Samples from age-matched controls (n=253), sporadic AD (SAD, n=256) and familial AD (FAD, n=140) were screened with DHPLC methodology followed by sequencing. Scanning the gene identified for the first time a missense mutation (D90N) in a patient with FAD. Three intronic polymorphisms were also identified, one of which had a higher presence of the mutated allele in AD subjects carrying the allele epsilon4 of apolipoprotein E than controls. The pathogenic role of the PEN-2 D90N mutation in AD is not clear, but the findings might lead to new studies on its functional and genetic role.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / genetics*
  • Amyloid Precursor Protein Secretases
  • Base Sequence
  • Blotting, Western
  • Chromatography, High Pressure Liquid
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Membrane Proteins / genetics*
  • Mutation*
  • Pedigree
  • Polymorphism, Genetic
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Membrane Proteins
  • PSENEN protein, human
  • Amyloid Precursor Protein Secretases